LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF | MicrobiomeTrials← Back to trialsNCT05983250
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2024-01-10Est. Completion: 2026-06-30
Enrollment target: 230 participants Locations- Tenax Investigational Site, Tucson, Arizona, United States
- Tenax Investigational Site, La Jolla, California, United States
- Tenax Investigational Site, Los Angeles, California, United States
- Tenax Investigational Site, Los Angeles, California, United States
- Tenax Investigational Site, Sacramento, California, United States
- Tenax Investigational Site, San Francisco, California, United States
- Tenax Investigational Site, Torrance, California, United States
- Tenax Investigational Site, Jacksonville, Florida, United States
- Tenax Investigational Site, Winter Haven, Florida, United States
- Tenax Investigational Site, Atlanta, Georgia, United States
- Tenax Investigational Site, Chicago, Illinois, United States
- Tenax Investigational Site, Chicago, Illinois, United States
- Tenax Investigational Site, Galesburg, Illinois, United States
- Tenax Investigational Site, Indianapolis, Indiana, United States
- Tenax Investigational Site, Indianapolis, Indiana, United States
- Tenax Investigational Site, Louisville, Kentucky, United States
Other microbiome trials you might be interested in
Venous ThromboembolismPostpartum PeriodAspirinLow Molecular Weight Heparin
The goal of the PARTUM trial is to determine if taking low-dose aspirin daily for 6 weeks after delivery is similar (non…
Brussels, BelgiumEst. completion Sep 2030
Heart Failure
Background:
More than 6.5 million people in the United States live with heart failure (HF), and more than a million new…
Falls Church, United StatesCompleted Apr 30, 2028
Tenax Investigational Site, Boston, Massachusetts, United StatesTenax Investigational Site, Minneapolis, Minnesota, United StatesTenax Investigational Site, Rochester, Minnesota, United StatesTenax Investigational Site, St Louis, Missouri, United StatesTenax Investigational Site, Omaha, Nebraska, United StatesTenax Investigational Site, New York, New York, United StatesTenax Investigational Site, New York, New York, United StatesTenax Investigational Site, Rochester, New York, United StatesTenax Investigational Site, Roslyn, New York, United StatesTenax Investigational Site, Durham, North Carolina, United StatesTenax Investigational Site, Greensboro, North Carolina, United StatesTenax Investigational Site, Cincinnati, Ohio, United StatesTenax Investigational Site, Columbus, Ohio, United StatesTenax Investigational Site, Pittsburgh, Pennsylvania, United StatesTenax Investigational Site, Providence, Rhode Island, United StatesTenax Investigational Site, Charleston, South Carolina, United StatesTenax Investigational Site, Columbia, South Carolina, United StatesTenax Investigational Site, Dallas, Texas, United StatesTenax Investigational Site, Dallas, Texas, United StatesTenax Investigational Site, Lubbock, Texas, United StatesTenax Investigational Site, Plano, Texas, United StatesTenax Investigational Site, Murray, Utah, United StatesTenax Investigational Site, Richmond, Virginia, United StatesTenax Investigational Site, Madison, Wisconsin, United StatesTenax Investigational Site, Winnipeg, Manitoba, CanadaTenax Investigational Site, London, Ontario, CanadaPulmonary Arterial Hypertension
This open-label extension study will evaluate the long-term effects of GB002 (seralutinib) in subjects who previously pa…
Sacramento, United StatesEst. completion Dec 2027